methyl 6-chloro-5-[(E)-3-oxo-3-phenyl-1-propenyl]-2-pyridinecarboxylate | 1256961-48-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: methyl 6-chloro-5-[(E)-3-oxo-3-phenyl-1-propenyl]-2-pyridinecarboxylate
• 英文别名: methyl 6-chloro-5-[(E)-3-oxo-3-phenyl-prop-1-enyl]pyridine-2-carboxylate；methyl 6-chloro-5-[(E)-3-oxo-3-phenylprop-1-enyl]pyridine-2-carboxylate
• CAS: 1256961-48-4
• 化学式: C₁₆H₁₂ClNO₃
• 分子量: 301.729
• InChiKey: ACCRRCZKDINBJT-CSKARUKUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  21
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  56.3
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  methyl 6-chloro-5-formyl-pyridine-2-carboxylate 、 苯甲酰三氟丙酮 在 哌啶 作用下， 以 二氯甲烷 为溶剂， 反应 5.0h， 以92%的产率得到methyl 6-chloro-5-[(E)-3-oxo-3-phenyl-1-propenyl]-2-pyridinecarboxylate
  参考文献：
  名称：

  合成（E）-α，β-不饱和酯和酮的新方法

  摘要：

  在哌啶存在下，羰基化合物与4,4,4,4-三氟乙酰乙酸乙酯和三氟取代的1,3-二酮反应，可以实现（E）-α，β-不饱和酯和酮的一般和实用合成在室温（≈40°C）下于二氯甲烷中具有出色的立体选择性（参见方案）。

  DOI：

  10.1002/chem.201000883

文献信息

• New and Facile Approach for the Synthesis of ( <i>E</i> )‐α,β‐Unsaturated Esters and Ketones
  作者：Bhimapaka China Raju、Pathi Suman

  DOI：10.1002/chem.201000883

  日期：2010.10.18

  A general and practical synthesis of (E)‐α,β‐unsaturated esters and ketones was achieved by the reaction of carbonyl compounds with ethyl‐4,4,4‐trifluoroacetoacetate and trifluoro‐substituted 1,3‐diketones in the presence of piperidine in dichloromethane at room temperature (≈40 °C) with excellent stereoselectivity (see scheme).

  在哌啶存在下，羰基化合物与4,4,4,4-三氟乙酰乙酸乙酯和三氟取代的1,3-二酮反应，可以实现（E）-α，β-不饱和酯和酮的一般和实用合成在室温（≈40°C）下于二氯甲烷中具有出色的立体选择性（参见方案）。
• Anti-mycobacterial, cytotoxic activities of Knoevenagel and (E)-α,β-unsaturated esters and ketones from 2-chloronicotinaldehydes
  作者：Pathi Suman、Rayala Nageswara Rao、Bhimapaka China Raju、Dharmarajan Sriram、Pulla Venkat Koushik

  DOI：10.1007/s00044-013-0622-4

  日期：2014.1

  Series of 2-chloronicotinaldehyde Knoevenagel derivatives 3a-r; (E)-alpha,beta-unsaturated esters and ketones 5a-k were prepared and evaluated for their in vitro anti-mycobacterial activity against Mycobacterium tuberculosis H(37)Rv (Mtb). Compounds 3e, 5b, 5d, 5e, 5g and 5i-k were shown potent to significant activity. Compound 5j is the most potent Mtb inhibitor (MIC: 4.89 mu M) when compared to standard drugs Ethambutol (MIC: 7.63 mu M) and Ciprofloxacin (MIC: 9.44 mu M). Eight compounds displayed potent/significant activity against M. tuberculosis were chosen for the cytotoxicity against three cell lines (Raw 264.7, MCF7, and HeLa). Compound 5j displayed low toxicity with high selective index (15-30) and is an interesting new compound may serve for the development of therapeutics targeted against anti-mycobacterial compounds. This is the first report assigning in vitro anti-mycobacterial inhibitory activity and structure-activity relationship for this class of substituted 2-chloronicotinaldehyde derivatives and presents new family of compounds.